Chorioamnionitis and increased galectin-1 expression in PPROM - An anti-inflammatory response in the fetal membranes?

American Journal of Reproductive Immunology

Volumn 60, Issue 4, 2008, Pages 298-311

  Than, Nandor Gabor ^a   Kim, Sung Su ^a   Abbas, Asad ^a   Han, Yu Mi ^a   Hotra, John ^a   Tarca, Adi L ^a   Erez, Offer ^a,b   Wildman, Derek E ^a,b   Kusanovic, Juan Pedro ^a,b   Pineles, Beth ^a   Montenegro, Daniel ^a   Edwin, Samuel S ^a   Mazaki tovi, Shali ^a,b   Gotsch, Francesca ^a   Espinoza, Jimmy ^a,b   Hassan, Sonia S ^a,b   Papp, Zoltan ^c   Romero, Roberto ^a,b  

^a HUTZEL HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Chorioamniotic fibroblast myofibroblast and macrophage; Chorioamniotic membranes; Inflammation; Lectin; Pre labor rupture of membranes; Pre term delivery

Indexed keywords

GALECTIN 1; MESSENGER RNA;

ADULT; AMNION CELL; ARTICLE; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS MEMBRANE; FIBROBLAST; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MACROPHAGE; MEMBRANE RUPTURE; MYOFIBROBLAST; PREMATURE LABOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST;

CHORIOAMNIONITIS; CROSS-SECTIONAL STUDIES; EXTRAEMBRYONIC MEMBRANES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GALECTIN 1; HUMANS; PREGNANCY; RNA, MESSENGER;

EID: 51649107124     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00624.x     Document Type: Article

References (65)

1. Bryant-Greenwood TD, Millar LK: Human fetal membranes: their preterm premature rupture. Biol Reprod 2000; 63: 1575-1579.
2. Mercer BM: Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101: 178-193.
3. Srinivas SK, Macones GA: Preterm premature rupture of the fetal membranes: Current concepts. Minerva Ginecol 2005; 57: 389-396.
4. Romero R, Espinoza J, Kusanovic J, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M: The preterm parturition syndrome. BJOG 2006; 113 (Suppl 3): 17-42.
5. Santolaya-Forgas J, Romero R, Espinoza J, Erez O, Friel LA, Kusanovic JP, Bahado-Singh R, Nien JK: Prelabor rupture of the membranes. In Clinical Obstetrics: The Fetus and Mother, EA Reece, JC Hobbins (eds). Oxford, UK, Blackwell Publishing, 2007, pp 1130-1188.
6. Redline RW: Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med 2006; 11: 296-301.
7. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM: The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202.
8. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, Ghezzi F, Berry SM, Qureshi F, Jacques SM, Kim JC, Kadar N, Romero R: Funisitis and chorionic vasculitis: The histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002; 11: 18-25.
9. Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, Tromp G, Espinoza J, Bujold E, Abrahams VM, Mor G: Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004; 191: 1346-1355.
10. Kjaergaard N, Hein M, Hyttel L, Helmig RB, Schonheyder HC, Uldbjerg N, Madsen H: Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol 2001; 94: 224-229.
11. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M: Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5: 81-88.
12. Romero R, Avila C, Santhanam U, Sehgal PB: Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990; 85: 1392-1400.
13. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I: Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165: 813-820.
14. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S: Evidence for interleukin-10-mediated inhibition of cyclo- oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006; 55: 19-27.
15. Peltier MR: Immunology of term and preterm labor. Reprod Biol Endocrinol 2003; 1: 122.
16. Bevan BH, Kilpatrick DC, Liston WA, Hirabayashi J, Kasai K: Immunohistochemical localization of a beta-D-galactoside-binding lectin at the human maternofetal interface. Histochem J 1994; 26: 582-586.
17. Maquoi E, van den Brule FA, Castronovo V, Foidart JM: Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 1997; 18: 433-439.
18. Vicovac L, Jankovic M, Cuperlovic M: Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod 1998; 13: 730-735.
19. von Wolff M, Wang X, Gabius HJ, Strowitzki T: Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol Hum Reprod 2005; 11: 189-194.
20. Than NG, Erez O, Wildman DE, Edwin S, Mazaki-Tovi S, Gotsch F, Cushenberry E, Pineles B, Montenegro D, Espinoza J, Kim CJ, Hassan S, Papp Z, Romero R: Preterm labor and preterm PROM are characterized by an increase in maternal serum concentration of galectin-1. Reprod Sci 2007; 14, 90A [Abstract].
21. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt AA, Hirabayashi J, Hughes C, Kasai K: Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994; 76: 597-598.
22. Camby A, Le MercierM, Lefranc F, Kiss R: Galectin-1: a small protein with major functions. Glycobiology 2006; 16: 137-157.
23. Rubinstein N, Ilarregui JM, Toscano MA, Rabinovich GA: The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens 2004; 64: 1-12.
24. Baum LG, Seilhamer JJ, Pang M, Levine WB, Beynon D, Berliner JA: Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj J 1995; 12: 63-68.
25. Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI: Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells. Blood 2007; 109: 2058-2065.
26. Gil CD, Cooper D, Rosignoli G, Perretti M, Oliani SM: Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis. Inflamm Res 2006; 55: 99-107.
27. Wang L, Friess H, Zhu Z, Frigeri L, Zimmermann A, Korc M, Berberat PO, Buchler MW: Galectin-1 and galectin-3 in chronic pancreatitis. Lab Invest 2000; 80: 1233-1241.
28. Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA: Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 2007; 58: 238-254.
29. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M: A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163-168.
30. Blanc WA: Amniotic infection syndrome; pathogenesis, morphology, and significance in circumnatal mortality. Clin Obstet Gynecol 1959;2: 705-734.
31. Redline RW: Placental inflammation. Semin Neonatol 2004; 9: 265-274.
32. Jeschke U, Mayr D, Schiessl B, Mylonas I, Schulze S, Kuhn C, Friese K, Walzel H: Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 2007; 28: 1165-1173.
33. Choe YS, Shim C, Choi D, Lee CS, Lee KK, Kim K: Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation. Mol Reprod Dev 1997; 48: 261-266.
34. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13: 1450-1457.
35. De Gregorio E, Chiariotti L, Di Nocera PP: The overlap of Inr and TATA elements sets the use of alternative transcriptional start sites in the mouse galectin-1 gene promoter. Gene 2001; 268: 215-223.
36. Than NG, Erez O, Wildman DE, Tarca AL, Edwin SS, Abbas A, Hotra J, Kusanovic JP, Gotsch F, Hassan SS, Espinoza J, Papp Z, Romero R: Severe preeclampsia is characterized by increased placental expression of galectin-1. J Matern Fetal Neonatal Med 2008; 21: 429-442.
37. van Herendael BJ, Oberti C, Brosens I: Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study. Am J Obstet Gynecol 1978; 131: 872-880.
38. Moiseeva EP, Williams B, Samani NJ: Galectin 1 inhibits incorporation of vitronectin and chondroitin sulfate B into the extracellular matrix of human vascular smooth muscle cells. Biochim Biophys Acta 2003; 1619: 125-132.
39. Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A: Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 2001; 32: 1036-1042.
40. Fulcher JA, Hashimi ST, Levroney EL, Pang M, Gurney KB, Baum LG, Lee B: Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix. J Immunol 2006; 177: 216-226.
41. Sutton L, Mason DY, Redman CW: HLA-DR positive cells in the human placenta. Immunology 1983; 49: 103-112.
42. Benirschke K, Kaufmann P, Baergen RN: Infectious diseases. In Pathology of the Human Placenta, 5th edn, New York, Springer Verlag, 2006, pp 657-732.
43. Eis AL, Brockman DE, Myatt L: Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am J Reprod Immunol 1997; 38: 289-294.
44. Espinoza J, Chaiworapongsa T, Romero R, Edwin S, Rathnasabapathy C, Gomez R, Bujold E, Camacho N, Kim YM, Hassan S, Blackwell S, Whitty J, Berman S, Redman M, Yoon BH, Sorokin Y: Antimicrobial peptides in amniotic fluid: Defensins, calprotectin and bacterial/ permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003; 13: 2-21.
45. Barrionuevo P, Beigier-Bompadre M, Ilarregui JM, Toscano MA, Bianco GA, Isturiz MA, Rabinovich GA: A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/ macrophage physiology through a nonapoptotic ERK-dependent pathway. J Immunol 2007; 178: 436-445.
46. Correa SG, Sotomayor CE, Aoki MP, Maldonado CA, Rabinovich GA: Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages. Glycobiology 2003;13: 119-128.
47. Dua HS, Gomes JA, King AJ, Maharajan VS: The amniotic membrane in ophthalmology. Surv Ophthalmol 2004; 49: 51-77.
48. Li H, Niederkorn JY, Neelam S, Mayhew E, Word RA, McCulley JP, Alizadeh H: Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 2005; 46: 900-907.
49. Park WC, Tseng SC: Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci 2000; 41: 2906-2914.
50. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K: Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001; 20: 408-413.
51. Sampson JE, Theve RP, Blatman RN, Shipp TD, Bianchi DW, Ward BE, Jack RM: Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 1997; 176: 77-81.
52. Perillo NL, Pace KE, Seilhamer JJ, Baum LG: Apoptosis of T cells mediated by galectin-1. Nature 1995; 378: 736-739.
53. Rabinovich GA, Sotomayor CE, Riera CM, Bianco I, Correa SG: Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 2000; 30: 1331-1339.
54. Baum LG, Blackall DP, Arias-Magallano S, Nanigian D, Uh SY, Browne JM, Hoffmann D, Emmanouilides CE, Territo MC, Baldwin GC: Amelioration of graft versus host disease by galectin-1. Clin Immunol 2003; 109: 295-307.
55. He J, Baum LG: Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab Invest 2006; 86: 578-590.
56. Ion G, Fajka-Boja R, Kovacs F, Szebeni G, Gombos I, Czibula A, Matko J, Monostori E: Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1. Cell Signal 2006; 18: 1887-1896.
57. van der Leij J, van den Berg A, Harms G, Eschbach H, Vos H, Zwiers P, van WR, Groen H, Poppema S, Visser L: Strongly enhanced IL-10 production using stable galectin-1 homodimers. Mol Immunol 2007; 44: 506-513.
58. Gil CD, La M, Perretti M, Oliani SM: Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3. Cell Biol Int 2006; 30: 338-344.
59. Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP, Cummings RD: Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 2003; 278: 41282-41293.
60. Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, van KC: IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 2006; 107: 4930-4937.
61. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Sallace JL: Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007; 21: 325-332.
62. Kim SS, Romero R, Kim JS, Abbas A, Espinoza J, Kusanovic JP, Hassan S, Yoon BH, Kim CJ: Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo plasticity of chorioamniotic mesodermal cells of the human placenta. Lab Invest 2008; 88: 365-374.
63. Starzl TE, Zinkernagel RM: Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001; 1: 233-239.
64. Matzinger P:AThe danger model: a renewed sense of self. Science 2002; 296: 301-305.
65. Moffett A, Loke YW: The immunologiAal paradox of pregnancy: a reappraisal. Placenta 2004; 25: 1-8.